TransMedics [TMDX] vs Globus Medical [GMED] Detailed Stock Comparison

TransMedics

NASDAQ
Loading...

Globus Medical

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: TransMedics wins in 3 metrics, Globus Medical wins in 16 metrics, with 0 ties. Globus Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTransMedicsGlobus MedicalBetter
P/E Ratio (TTM)58.4323.44Globus Medical
Price-to-Book Ratio12.381.90Globus Medical
Debt-to-Equity Ratio163.102.83Globus Medical
PEG Ratio0.330.04Globus Medical
EV/EBITDA40.5010.96Globus Medical
Profit Margin (TTM)13.49%13.58%Globus Medical
Operating Margin (TTM)23.24%17.33%TransMedics
EBITDA Margin (TTM)23.24%17.33%TransMedics
Return on Equity28.21%8.62%TransMedics
Return on Assets (TTM)5.80%5.82%Globus Medical
Free Cash Flow (TTM)$-80.94M$405.21MGlobus Medical
1-Year Return-15.73%-14.74%Globus Medical
Price-to-Sales Ratio (TTM)7.423.11Globus Medical
Enterprise Value$4.06B$8.06BGlobus Medical
EV/Revenue Ratio7.653.07Globus Medical
Gross Profit Margin (TTM)61.38%66.62%Globus Medical
Revenue per Share (TTM)$16$19Globus Medical
Earnings per Share (Diluted)$1.98$2.58Globus Medical
Beta (Stock Volatility)2.071.12Globus Medical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

TransMedics vs Globus Medical Stock Performance Analysis

Loading Price Chart...

TransMedics
Globus Medical
TransMedics Stock Overview | Globus Medical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TransMedics-1.52%1.15%7.91%-8.98%64.76%71.32%
Globus Medical-0.51%6.65%1.04%7.50%-14.95%-26.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TransMedics-15.73%191.53%742.68%359.40%359.40%359.40%
Globus Medical-14.74%-0.99%8.69%158.80%345.70%345.70%

News Based Sentiment: TransMedics vs Globus Medical

TransMedics

News based Sentiment: POSITIVE

TransMedics experienced a month of largely positive developments, including analyst upgrades, institutional investment, and a significant partnership, offsetting a slight downward revision in Q3 revenue projections. The company's strong long-term growth trajectory and innovative technology continue to attract investor interest, making it a compelling investment story.

View TransMedics News Sentiment Analysis

Globus Medical

News based Sentiment: MIXED

Globus Medical is showing strong financial growth and innovation, but a declining stock price and decreasing ROIC create a mixed investment picture. The positive analyst ratings and strong market position suggest potential, but investors should carefully monitor key performance indicators and market signals.

View Globus Medical News Sentiment Analysis

Performance & Financial Health Analysis: TransMedics vs Globus Medical

MetricTMDXGMED
Market Information
Market Cap i$4.00B$8.17B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i716,2601,666,320
90 Day Avg. Volume i946,8931,314,997
Last Close$113.93$60.17
52 Week Range$55.00 - $145.50$51.79 - $94.93
% from 52W High-21.70%-36.62%
All-Time High$177.37 (Aug 19, 2024)$94.93 (Jan 27, 2025)
% from All-Time High-35.77%-36.62%
Growth Metrics
Quarterly Revenue Growth0.38%0.18%
Quarterly Earnings Growth1.86%5.39%
Financial Health
Profit Margin (TTM) i0.13%0.14%
Operating Margin (TTM) i0.23%0.17%
Return on Equity (TTM) i0.28%0.09%
Debt to Equity (MRQ) i163.102.83
Cash & Liquidity
Book Value per Share (MRQ)$9.35$31.81
Cash per Share (MRQ)$11.75$1.70
Operating Cash Flow (TTM) i$115.27M$669.16M
Levered Free Cash Flow (TTM) i$-7,754,500$456.11M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: TransMedics vs Globus Medical

MetricTMDXGMED
Price Ratios
P/E Ratio (TTM) i58.4323.44
Forward P/E i70.1217.68
PEG Ratio i0.330.04
Price to Sales (TTM) i7.423.11
Price to Book (MRQ) i12.381.90
Market Capitalization
Market Capitalization i$4.00B$8.17B
Enterprise Value i$4.06B$8.06B
Enterprise Value Metrics
Enterprise to Revenue i7.653.07
Enterprise to EBITDA i40.5010.96
Risk & Other Metrics
Beta i2.071.12
Book Value per Share (MRQ) i$9.35$31.81

Financial Statements Comparison: TransMedics vs Globus Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TMDXGMED
Revenue/Sales i$157.37M$598.12M
Cost of Goods Sold i$60.78M$195.40M
Gross Profit i$96.59M$402.72M
Research & Development i$15.93M$33.06M
Operating Income (EBIT) i$36.57M$98.06M
EBITDA i$45.79M$160.92M
Pre-Tax Income i$36.18M$103.67M
Income Tax i$1.28M$28.21M
Net Income (Profit) i$34.91M$75.46M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TMDXGMED
Cash & Equivalents i$310.14M$461.27M
Total Current Assets i$505.92M$1.71B
Total Current Liabilities i$55.60M$384.70M
Long-Term Debt i$515.62M$81.69M
Total Shareholders Equity i$266.31M$4.09B
Retained Earnings i$-442.56M$1.04B
Property, Plant & Equipment i$40.54M$1.06B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TMDXGMED
Operating Cash Flow i$354,000$193.84M
Capital Expenditures i$-27.04M$-36.10M
Free Cash Flow i$-29.89M$136.20M
Debt Repayment iN/A$-449.99M
Common Stock Repurchase iN/A$-190.45M

Short Interest & Institutional Ownership Analysis

MetricTMDXGMED
Shares Short i8.39M6.59M
Short Ratio i8.816.55
Short % of Float i0.42%0.07%
Average Daily Volume (10 Day) i716,2601,666,320
Average Daily Volume (90 Day) i946,8931,314,997
Shares Outstanding i33.62M137.42M
Float Shares i32.96M111.74M
% Held by Insiders i0.03%0.01%
% Held by Institutions i1.10%1.03%

Dividend Analysis & Yield Comparison: TransMedics vs Globus Medical

MetricTMDXGMED
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A